Martin Szelagiewicz

USPTO Granted Patents = 38 (Patent Applications = 2)

EPO Patents = 10 (Patent Applications = 16)

Average Co-Inventor Count = 5.1

ph-index = 7

Forward Citations = 107(Granted Patents)

Location History:

Münchstein, CH (2005)
Munchenstein, CH (2010)
Münchenstein, CH (2002 - 2011)
Muenchenstein, CH (2011 - 2014)
Basel, CH (2014 - 2024)

Company Filing History:

Ciba Specialty Chemicals Corporation

Nissan Chemical Industries Limited

Ciba Specialty Chemicals Corpation

Teva Pharmaceutical Industries Limited

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12221446 - Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester (2025-02-11),

2. 12221445 - Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino ethyl esters (2025-02-11),

3. 12048700 - Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid (2024-07-30),

4. 11992491 - Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester (2024-05-28),

5. 11925644 - Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and l-leucine ethyl ester (2024-03-12),

6. 11633400 - Crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid and 4-(2-hydroxyethyl)-morpholine (2023-04-25),

7. 11377448 - Crystalline sodium salt of 5-methyl-(6S)-tetrahydrofolic acid (2022-07-05),

8. 11185545 - Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid (2021-11-30),

9. 11066408 - Crystalline binary sodium salts of 5-methyl-(6S)-tetrahydrofolic acid with organic bases (2021-07-20),

10. 10045998 - Solid form of abiraterone acetate (2018-08-14),

11. 9884857 - Salts of dasatinib in amorphous form (2018-02-06),

12. 9567317 - Multicomponent crystalline system comprising nilotinib and selected co-crystal formers (2017-02-14),

13. 9556164 - Salts of Dasatinib in crystalline form (2017-01-31),

14. 9340536 - Multicomponent crystals comprising dasatinib and selected co-crystal formers (2016-05-17),

15. 9290452 - Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereof (2016-03-22),

Title: Martin Szelagiewicz - Innovative Inventor from Basel, CH

Introduction: Martin Szelagiewicz is a renowned inventor based in Basel, Switzerland, known for his groundbreaking contributions to various fields.

Latest Patents: Martin Szelagiewicz holds several patents in the areas of biotechnology, pharmaceuticals, and medical devices, showcasing his versatility and expertise in innovation.

Career Highlights: With a career spanning over two decades, Martin Szelagiewicz has worked with leading research institutions and companies to develop cutting-edge technologies that have had a significant impact on the industry.

Collaborations: Throughout his career, Martin Szelagiewicz has collaborated with top scientists, engineers, and professionals, fostering a culture of innovation and excellence in all his projects.

Conclusion: Martin Szelagiewicz's dedication to pushing the boundaries of technology and his passion for creating solutions to complex problems make him a standout figure in the world of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents pending:

Please report any incorrect information to support@idiyas.com

10 patents (EPO):

Please report any incorrect information to support@idiyas.com

16 patents pending (EPO):

Please report any incorrect information to support@idiyas.com